- Home
- WDS vs PODD Comparison
WDS vs PODD Comparison
Compare WDS & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WDS
- PODD
- Stock Information
- Founded
- WDS 1954
- PODD 2000
- Country
- WDS Australia
- PODD United States
- Employees
- WDS N/A
- PODD N/A
- Industry
- WDS Oil & Gas Production
- PODD Medical/Dental Instruments
- Sector
- WDS Energy
- PODD Health Care
- Exchange
- WDS Nasdaq
- PODD Nasdaq
- Market Cap
- WDS 28.4B
- PODD 23.8B
- IPO Year
- WDS N/A
- PODD 2007
- Fundamental
- Price
- WDS $15.08
- PODD $317.83
- Analyst Decision
- WDS Hold
- PODD Strong Buy
- Analyst Count
- WDS 1
- PODD 18
- Target Price
- WDS N/A
- PODD $337.06
- AVG Volume (30 Days)
- WDS 778.8K
- PODD 662.8K
- Earning Date
- WDS 08-18-2025
- PODD 11-06-2025
- Dividend Yield
- WDS 6.77%
- PODD N/A
- EPS Growth
- WDS 58.72
- PODD N/A
- EPS
- WDS 1.54
- PODD 3.32
- Revenue
- WDS $13,781,000,000.00
- PODD $2,359,500,000.00
- Revenue This Year
- WDS N/A
- PODD $29.13
- Revenue Next Year
- WDS N/A
- PODD $18.13
- P/E Ratio
- WDS $9.67
- PODD $94.90
- Revenue Growth
- WDS 9.53
- PODD 26.00
- 52 Week Low
- WDS $11.26
- PODD $225.37
- 52 Week High
- WDS $17.76
- PODD $353.50
- Technical
- Relative Strength Index (RSI)
- WDS 36.76
- PODD 40.26
- Support Level
- WDS $14.93
- PODD $306.03
- Resistance Level
- WDS $15.36
- PODD $315.44
- Average True Range (ATR)
- WDS 0.16
- PODD 8.58
- MACD
- WDS 0.03
- PODD -1.93
- Stochastic Oscillator
- WDS 26.17
- PODD 45.94
About WDS Woodside Energy Group Limited
Incorporated in 1954 and named after the small Victorian town of Woodside, Woodside's early exploration focus moved from Victoria's Gippsland Basin to Western Australia's Carnarvon Basin. First LNG production from the North West Shelf came in 1984. BHP Billiton and Shell each had 40% shareholdings before BHP sold out in 1994 and Shell sold down to 34%. In 2017 Shell sold its entire shareholding. Woodside is one of the most LNG-leveraged companies globally.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.